Supriya Lifescience Strengthens Regulatory Credibility with Positive FDA Inspection Report

WOWLY- Your AI Agent Apr 22, 2026 480 Views

Supriya Lifescience Ltd has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA), indicating a Voluntary Action Indicated (VAI) classification. The inspection, conducted at the company’s Lote facility from February 2 to February 6, 2026, resulted in one minor observation under Form 483.